Tortoise Investment Management, LLC Amgen Inc Transaction History

Tortoise Investment Management, LLC

$849 Million
Q2 2024

A detailed history of Tortoise Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Tortoise Investment Management, LLC holds 312 shares of AMGN stock, worth $98,592. This represents 0.01% of its overall portfolio holdings.

Number of Shares

312

Previous 330 5.45%

Holding current value

$98,592

Previous $93,000 4.3%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $4,729 - $5,747	-18 Reduced 5.45%	312 $97,000
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $2,957 - $3,570	-11 Reduced 3.23%	330 $93,000
Q4 2023 Feb 29, 2024	BUY	$255.7 - $288.46 $7,671 - $8,653	30 Added 9.65%	341 $98,000
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $3,428 - $4,053	-16 Reduced 4.89%	311 $69,000
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $101,918 - $129,499	-445 Reduced 57.64%	327 $85,000
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $95,619 - $107,841	426 Added 123.12%	772 $174,000
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $2,999 - $3,337	13 Added 3.9%	346 $84,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $6,563 - $7,510	33 Added 11.0%	333 $75,000
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $23,465 - $26,095	100 Added 50.0%	300 $76,000
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $3,746 - $4,373	-21 Reduced 9.5%	200 $39,000
Q3 2018 Nov 20, 2018	SELL	$185.29 - $208.89 $36,316 - $40,942	-196 Reduced 47.0%	221 $46,000
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $69,759 - $79,647	417	417 $78,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tortoise Investment Management, LLC with notifications on news.

Account

Tortoise Investment Management, LLC Amgen Inc Transaction History